Calliditas Announces Positive NefIgArd Open Label Extension Results ...Middle East

STOCKHOLM, April 24, 2024 /PRNewswire/ -- Calliditas Therapeutics AB (NASDAQ: CALT), (NASDAQ STOCKHOLM: CALTX) ("Calliditas") today announced that the global open-label extension (OLE) study to the Phase 3 NefIgArd study showed a treatment response consistent with the NefIgArd study...

Hence then, the article about calliditas announces positive nefigard open label extension results was published today ( Wednesday 24/04/2024 - 10:33 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Calliditas Announces Positive NefIgArd Open Label Extension Results )

Also on site :

• Trump DOJ Refuses to Rule Out Second Amendment Right to Nuclear Weapons
• 53-year-old woman accused of stripping naked and assaulting customers in a Pennsylvania grocery store
• Is Europe heading to an energy crisis?